Foundation Venture, affiliated with New Jersey Health Foundation, announces backing for life sciences research firm MentiNova.

Foundation Venture Capital Group, a New Jersey Health Foundation affiliate that invests exclusively in research at the University of Medicine and Dentistry of New Jersey (UMDNJ) by funding new life science companies, has backed MentiNova, which is exploring an oral medication that could reduce side-effects to treatments to Parkinson’s disease. 

Foundation has committed up to $500,000 to advance this research and development. 

In addition to MentiNova, other Foundation portfolio companies include: 

Actinobac Biomed, developing a therapeutic agent targeting blood cells…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?